Position in GSK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$61,964,004
-$27,959,877 QoQ
Shares Held
1,182,068
-27.5% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
1.67%
of 13F equity value
Holder Rank
#38
of 1,032 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MILLER HOWARD INVESTMENTS INC /NY holds $313,802,454 across 4 Drug Manufacturers - General names. GSK ranks #3 (19.7% of the industry book) .
All Filings in GSK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,964,004 | 1,182,068 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $89,923,881 | 1,629,351 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $80,529,270 | 1,642,114 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $71,715,087 | 1,661,610 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $63,736,857 | 1,659,814 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $63,796,683 | 1,646,791 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $23,366,238 | 690,900 | Shares | Sole | 2025-01-28 | |
| No filing history on record for this holder in this stock. | ||||||